While early cancer detection is the key to survival, many patients are diagnosed after the disease has progressed. A regular affordable screening test for ovarian and endometrial cancers would radically improve survival rates.
Inanna Diagnostics is developing a proprietary technology that enables isolation of a previously untapped source of DNA material for non-invasive early screening applications.
We are a team of seasoned scientists, entrepreneurs and diagnostics experts who have developed new science, built companies and delivered novel diagnostics solutions to the market.
Summary of technology
Our early cancer detection technology is based on the unique and patented method for processing pap smear samples.
Process to obtain DNA (IP)
DNA Sequencing (IP)
Analyze for low frequency mutant alleles
Report Screening Results